Advertisement

VolitionRx Limited VNRX

Set alert

Price alert · VNRX

All alert types
0.21 USD +0.01 +7.58%

At close · Nov 2

0.21 0.00 +2.00%

After hours · Nov 2, 5:50 PM ET

Bid
0.20 × 300
Ask
0.21 × 200
0.195 Day range 0.22
0.16 52-week range 9.60
YTD
-95.96%
1 year
-97.56%
Open
0.2001
Prev close
0.1953
Mkt cap
6.32M
Vol
1.24M
Avg vol
8.70M
EPS
-3.80
P/E
0.00
Div yield
0.00%
More statistics
Low
0.195
High
0.22
Forward P/E
-3.83
Beta
1.10
Short ratio
3.71
Inst. own
19.11%
Dividend
0.00
Ex-div date
50-d avg
0.6652
200-d avg
0.6969
1y target
3.34

2Y chart

Chart tools
Interval

Events in this range
  • Nov 14, 2024Earnings: -0.07; estimate -0.07; surprise 0%
  • Nov 15, 2024Rating: D. Boral Capital · Buy → Buy
  • Nov 22, 2024Rating: Benchmark · — → Hold
  • Dec 10, 2024Rating: D. Boral Capital · Buy → Buy
  • Apr 28, 2026Split: 1 for 20
Signals (89)
NameDateAgo
RSI: OversoldOct 7, 20263 weeks ago
RSI: OversoldSep 2, 20262 months ago
MACD: Buy SignalAug 27, 20262 months ago
MACD: Sell SignalAug 17, 20262 months ago
MACD: Buy SignalAug 5, 20262 months ago
MACD: Sell SignalJul 27, 20263 months ago
RSI: OversoldJul 24, 20263 months ago
RSI: OversoldJul 22, 20263 months ago
RSI: OversoldJul 17, 20263 months ago
MACD: Buy SignalJun 26, 20264 months ago
RSI: OversoldJun 23, 20264 months ago
RSI: OversoldJun 8, 20264 months ago
MACD: Sell SignalJun 4, 20265 months ago
SMA: BearishMay 26, 20265 months ago
SMA: BullishMay 22, 20265 months ago
MACD: Buy SignalMay 18, 20265 months ago
MACD: Sell SignalMay 15, 20265 months ago
RSI: OversoldMay 15, 20265 months ago
MACD: Buy SignalMay 14, 20265 months ago
MACD: Sell SignalApr 23, 20266 months ago
RSI: OversoldApr 23, 20266 months ago
MACD: Buy SignalApr 16, 20266 months ago
MACD: Sell SignalApr 6, 20267 months ago
MACD: Buy SignalFeb 26, 20268 months ago
SMA: BearishFeb 2, 20269 months ago
SMA: BullishJan 30, 20269 months ago
MACD: Sell SignalJan 26, 20269 months ago
SMA: BearishJan 21, 20269 months ago
SMA: BullishJan 20, 20269 months ago
SMA: BearishJan 14, 20269 months ago
SMA: BullishJan 8, 20269 months ago
MACD: Buy SignalDec 17, 202510 months ago
MACD: Sell SignalDec 16, 202510 months ago
RSI: OversoldDec 15, 202510 months ago
RSI: OversoldDec 3, 202511 months ago
RSI: OversoldDec 1, 202511 months ago
MACD: Buy SignalNov 26, 202511 months ago
MACD: Sell SignalNov 25, 202511 months ago
RSI: OversoldNov 25, 202511 months ago
MACD: Buy SignalNov 24, 202511 months ago
RSI: OversoldNov 19, 202511 months ago
MACD: Sell SignalNov 13, 202511 months ago
RSI: OversoldNov 11, 202511 months ago
MACD: Buy SignalOct 30, 20251 year ago
RSI: OversoldOct 22, 20251 year ago
RSI: OversoldOct 15, 20251 year ago
MACD: Sell SignalOct 10, 20251 year ago
RSI: OversoldOct 10, 20251 year ago
SMA: BearishOct 9, 20251 year ago
SMA: BearishOct 9, 20251 year ago
SMA: BullishOct 7, 20251 year ago
SMA: BearishOct 1, 20251 year ago
SMA: BullishSep 30, 20251 year ago
MACD: Buy SignalSep 30, 20251 year ago
SMA: BullishSep 26, 20251 year ago
SMA: BearishSep 25, 20251 year ago
MACD: Sell SignalSep 23, 20251 year ago
SMA: BearishSep 22, 20251 year ago
SMA: BullishSep 19, 20251 year ago
MACD: Buy SignalSep 19, 20251 year ago
SMA: BullishSep 8, 20251 year ago
SMA: BearishSep 5, 20251 year ago
MACD: Sell SignalSep 4, 20251 year ago
SMA: BearishAug 18, 20251 year ago
MACD: Buy SignalAug 18, 20251 year ago
SMA: BullishAug 15, 20251 year ago
SMA: BearishJul 31, 20251 year ago
MACD: Sell SignalJul 2, 20251 year ago
RSI: OverboughtJun 20, 20251 year ago
RSI: OverboughtJun 13, 20251 year ago
SMA: BullishJun 2, 20251 year ago
SMA: BearishMay 27, 20251 year ago
SMA: BullishMay 21, 20251 year ago
MACD: Buy SignalMay 21, 20251 year ago
MACD: Sell SignalMay 15, 20251 year ago
MACD: Buy SignalApr 24, 20251 year ago
MACD: Sell SignalApr 7, 20251 year ago
MACD: Buy SignalApr 3, 20251 year ago
MACD: Sell SignalApr 1, 20251 year ago
MACD: Buy SignalMar 31, 20251 year ago
MACD: Sell SignalMar 12, 20251 year ago
SMA: BearishMar 5, 20251 year ago
SMA: BullishFeb 27, 20251 year ago
MACD: Buy SignalFeb 27, 20251 year ago
MACD: Sell SignalFeb 21, 20251 year ago
SMA: BearishFeb 18, 20251 year ago
SMA: BullishFeb 14, 20251 year ago
MACD: Buy SignalFeb 14, 20251 year ago
MACD: Sell SignalJan 22, 20251 year ago

Key statistics

Market cap
58.84M
Enterprise value
61.40M
Trailing P/E
0.00
Forward P/E
-3.83
PEG ratio
0.00
Price / sales
60.25
Price / book
0.00
EPS (TTM)
-0.36
Beta
1.10
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
976.52K
Revenue growth
83.00%
Free cash flow
-5.70M
Total cash
6.00M
Total debt
5.86M
Return on equity
0.00%
Shares outstanding
95.97M
Short % of float
0.61%
50-day average
0.6652
200-day average
0.6969

Analyst view

Consensus: buy

Buy
Price target (mean) 3.34 +1489.7% upside
Target (low)
2.00
Target (mean)
3.34
Target (high)
5.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.05.

Earnings history

Financials — quick view

All financials
VNRX Revenue — quarterly 398.66K
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
VNRX Net income — quarterly -7.33M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
VNRX EPS — quarterly -0.85
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

VNRX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 2024-0.07-0.070.000.00%
Aug 14, 2024Jun 1, 2024-0.09-0.08+0.01+11.11%
May 13, 2024Mar 1, 2024-0.11-0.10+0.01+9.09%
Mar 25, 2024Dec 1, 20230.00-0.11——
Nov 14, 2023Sep 1, 2023-0.12-0.11+0.01+8.33%
Aug 14, 2023Jun 1, 2023-0.13-0.14-0.01-7.69%

Upgrades / downgrades

VNRX analyst upgrades and downgrades
DateFirmActionFromTo
Dec 10, 2024D. Boral CapitalmainBuyBuy
Nov 22, 2024Benchmarkreit—Hold
Nov 15, 2024D. Boral CapitalmainBuyBuy
Nov 1, 2024EF HuttonmainBuyBuy
Aug 16, 2024Benchmarkreit—Hold
Jun 7, 2024EF HuttonmainBuyBuy

About VolitionRx Limited

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
Website
volition.com

News

Your note

Sign in to keep a note on VNRX — it syncs with the Stock Master app.

Insider holders

VNRX insider holders
InsiderRelationLatest transactionDateShares held
BUTERA SALVATORE THOMASOfficerStock Award(Grant)Nov 28, 2024392,940
COLMAN ALANDirectorStock Award(Grant)Nov 28, 2024230,524
FORTERRE GAELOfficerStock Award(Grant)Nov 28, 2024194,681
HUGHES TERIGChief Financial OfficerStock Award(Grant)Nov 28, 2024376,252
INNES GUY ARCHIBALDDirectorPurchaseDec 8, 20242,991,100
KWAY JASMINEOfficerStock Award(Grant)Nov 28, 2024176,472

Institution ownership

VNRX institution ownership
Holder% heldSharesValueReported
Armistice Capital, LLC9.71%8,998,7275.52MSep 29, 2024
Lagoda Investment Management, L.P.6.58%6,095,0003.74MSep 29, 2024
Geode Capital Management, LLC0.79%730,448447.84KSep 29, 2024
Vanguard Group Inc0.69%636,667390.34KSep 29, 2024
Blackrock Inc.0.48%445,187272.94KSep 29, 2024
Silverberg Bernstein Capital Management LLC 0.15%142,61887.44KSep 29, 2024

Fund ownership

VNRX fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.67%622,949381.93KSep 29, 2024
Fidelity Extended Market Index Fund0.44%409,150250.85KOct 30, 2024
Fidelity Total Market Index Fund0.15%142,50687.37KOct 30, 2024
Fidelity Series Total Market Index Fund0.10%96,67659.27KOct 30, 2024
Schwab Capital Trust-Total Stock Market Index Fund0.02%15,3849.43KJul 30, 2024
Bridgeway Funds Inc-Ultra Small Company Market Fund0.02%18,08011.08KSep 29, 2024
Advertisement